sitagliptin/metformin zentiva (sitagliptin metformin zentiva) filmuhúðuð tafla 50 mg/1000 mg
zentiva k.s.* - metforminum hýdróklóríð; sitagliptinum hýdróklóríð - filmuhúðuð tafla - 50 mg/1000 mg
sitagliptin/metformin zentiva (sitagliptin metformin zentiva) filmuhúðuð tafla 50 mg/850 mg
zentiva k.s.* - metforminum hýdróklóríð; sitagliptinum hýdróklóríð - filmuhúðuð tafla - 50 mg/850 mg
sitagliptin zentiva filmuhúðuð tafla 50 mg
zentiva k.s.* - sitagliptinum hýdróklóríð - filmuhúðuð tafla - 50 mg
sitagliptin zentiva filmuhúðuð tafla 100 mg
zentiva k.s.* - sitagliptinum hýdróklóríð - filmuhúðuð tafla - 100 mg
sitagliptin zentiva filmuhúðuð tafla 25 mg
zentiva k.s.* - sitagliptinum hýdróklóríð - filmuhúðuð tafla - 25 mg
sitagliptin / metformin hydrochloride accord
accord healthcare s.l.u. - metformin hydrochloride, sitagliptin hydrochloride monohydrate - sykursýki, tegund 2 - lyf notuð við sykursýki - for adult patients with type 2 diabetes mellitus:it is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. it is indicated in combination with a sulphonylurea (i. , þrefaldur samsetning meðferð) sem viðbót til að fæði og æfing í sjúklingar ekki nægilega stjórn á eigin hámarks þolað skammt af sjúklingar og sulphonylurea. it is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. it is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.
sitagliptin/metformin medical valley filmuhúðuð tafla 50mg/1000 mg
medical valley invest ab - metforminum hýdróklóríð; sitagliptinum hýdróklóríð - filmuhúðuð tafla - 50mg/1000 mg
sitagliptin/metformin sandoz filmuhúðuð tafla 50/1000 mg
sandoz a/s* - metforminum hýdróklóríð; sitagliptinum hýdróklóríð - filmuhúðuð tafla - 50/1000 mg
sitagliptin/metformin krka filmuhúðuð tafla 50 mg/1000 mg
krka, d.d., novo mesto - sitagliptinum inn; metforminum hýdróklóríð - filmuhúðuð tafla - 50 mg/1000 mg
sitagliptin/metformin krka filmuhúðuð tafla 50 mg/850 mg
krka, d.d., novo mesto - sitagliptinum inn; metforminum hýdróklóríð - filmuhúðuð tafla - 50 mg/850 mg